Patients

Get help managing your health to feel your best—at no additional cost to you.

Helping Alice Avoid Dialysis

Because her health plan partners with Interwell Health, Alice got the support she needed from nurses and dietitians.

For Providers

Partner with value-based kidney care experts who understand your practice needs.

At Eastern Nephrology Associates, Value-Based Care Delivers Results that Matter

In partnership with Interwell Health, Eastern Nephrology transformed patient outcomes by embracing a value-based care approach, achieving an 85 percent optimal dialysis start rate, a nearly five-fold increase in preemptive transplant referrals, and leading scores in the government’s value-based kidney care model.

For Payers

Working together to lower total cost of care and improve patient outcomes.

5 Ways to Improve HEDIS Performance

Adopting a value-based kidney care model can help close gaps in care and improve HEDIS scores for five key measures.

Resources

Educational resources for patients and industry insights for providers and payers.

Kidney Health Connections

Podcasts, webinars, and more that bridge the gap between industry expertise and payer needs.

About Us

We are transforming kidney care, setting the standard for the industry, and helping patients live their best lives.

Interwell Health CEO on Leading with Clarity and Bringing Care Closer to the Patient

Interwell Health CEO Tommy O’Connor shares his perspective on staying focused on what matters most, what sets Interwell apart in kidney care, and building a better patient experience.

Key Clinical and Administrative Leaders

Maritza Izquierdo

SVP, Value Based Programs
Interwell Health

Carney Taylor

Associate Chief Medical Officer
Interwell Health

Maureen Bernacki

VP Finance
Interwell Health

Primary Contact

Maritza Izquierdo

SVP, Value Based Programs

Interwell Health

maritza.izquierdo@interwellhealth.com

(512) 277-6565

Participants

NEPHROLOGY ASSOCIATES OF UTAH LLC

  • ANDREW CORTEZ
  • ARASU GOPINATH
  • BROCK HIGGS
  • DAVE TIEN
  • DONALD MORRIS
  • INDRANEEL MOGARALA
  • JAMES SHAFFNER
  • JEFF BARKLOW
  • JENNIFER SORTO
  • JERALD BOSEMAN
  • KEVIN JANSEN
  • LANDON DICKSON
  • MARCELLUS ASSIAGO
  • PHYLLIS ASELTINE
  • ROMAN SHINGAREV
  • RON ZUIDERWEG
  • RUTH INDAHYUNG
  • SANJIV ANAND
  • SEY LAU
  • SHARIQ AHMAD
  • TRENTON GRAY
  • ZHAN WANG
  • ZUBAIR SAEED ZAFAR

ONEILL CLARK NARVARTE & VICKS A PROFESSIONAL CORPORATION

  • ARIKA GUPTA
  • IRYNA PATEL
  • JAMES SULLIVAN
  • JAVIER NARVARTE
  • JENNY SANCHEZ
  • JOSEPH DOAN
  • JUSMIN PATEL
  • KAI CHIN
  • KRISTINA SPITALE-EFSTRATIS
  • LINDSAY GRAY
  • LINDSAY SANDERS
  • MARK SIEVERT
  • MICHELLE TAVENER
  • MUKESH SHARMA
  • NINA PATYNOWSKI
  • RIDHMI RAJAPAKSE
  • ROBERT QUIGLEY
  • SAKSHI YADAV
  • SARAH QUINN
  • SHEERY MARIE VILLAGRACIA
  • SHIVA ADHAM
  • SONI DHANIREDDY
  • SUNIL SKARIA

ST GEORGE KIDNEY CARE LLC

  • ANDREW PATCHETT
  • CARLOS LEON
  • CARLOS MERCADO
  • GREG LARSEN
  • SHEILA LARSEN

Company

Interwell Health

177 Huntington Ave Ste 1703 PMB 39516

Boston, Massachusetts 02115-3153

Governing Body

Independent Consumer Advocate

Glen Kemper

Interwell Health

Maritza Izquierdo

Nephrology Associates of Utah, LLC

Justice Achilli

Oneill Clark Narvarte & Vicks A Professional Corporation

Mark Sievert

St. George Kidney Care, LLC

Carlos Mercado

Transplant Provider – Nephrology Associates of Utah, LLC

Donald Morris

Results

Shared Savings and Shared Losses

PY 2022:   N/A

 

 

PY 2023:   $421,686.11

 

 

PY 2024:   $1,929,061.57

Shared Savings Distribution

PY 2022 Investments:N/A and N/A allocation
PY 2022 Distributions:N/A and N/A allocation
 
PY 2023 Investments:$163,001.04 and 38.7% allocation
PY 2023 Distributions:$258,685.07 and 61.3% allocation
 
PY 2024 Investments:$1,042,793.88 and 54.1% allocation
PY 2024 Distributions:$886,267.69 and 45.9% allocation

Quality Performance

The Total Quality Score (TQS) is based on the KCE's performance on quality measures and is scored on a

0 to 100 scale.

 

TQS for PY 2022:   N/A

 

 

TQS for PY 2023:   100.0%

 

 

TQS for PY 2024:   96.3%